Search

everythinglearnresearchcommunity

for

Search:↓

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

IgG4-related disease can cause scalp hair loss that looks like acne keloidalis nuchae.

A boy with Oculodentodigital syndrome had a unique GJA1 gene mutation causing his symptoms.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Baricitinib is effective and safe for treating severe alopecia areata.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

The Itpr3 gene causes a specific hair pattern in mice.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Gujian oral liquid reduces osteoarthritis symptoms by targeting inflammation.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

The document's content cannot be summarized because it is not accessible or understandable.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Immature blackbuck pancreas has underdeveloped goblet cells and similar Langerhans islets in both sexes.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.